Search This Blog

Thursday, May 31, 2018

Globus started at buy by Cantor


Globus Medical initiated with an Overweight at Cantor Fitzgerald. Cantor Fitzgerald analyst Craig Bijou started Globus Medical with an Overweight rating and $65 price target. The analyst sees several sales growth drivers for the company, including a U.S. core market rebound, early success of emerging technologies and traction of the acquired ATEC international platform.

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.